← Leaderboards
Chawnshang Chang
University Of Rochester
$14,165,223
Attributed
$16,468,277
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$16,468,277 · 14
By mechanism
R01$16,468,277 · 14
Top collaborators
- Shuyuan Yeh15 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Shuyuan Yeh$4,966,620
- Xinping Zhang$9,135,393
Others in their field
Top investigators on “Androgen Receptor”
- Susan E. Hankinson · University Of Massachusetts Amherst$24,278,267
- Diane E Merry · Thomas Jefferson University$17,810,180
- Charles L Sawyers · Sloan-Kettering Inst Can Research$17,232,913
- Richard D Schulick · Johns Hopkins University$17,086,121
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$16,194,198
- Xiaoqi Liu · Harvard University$15,300,481
Research focus
Androgen ReceptorAndrogensPlayKnock-OutGrowthCellsIn VivoIn VitroMouse ModelProstateMaleApoptosisAblationReceptor FunctionStromal CellsLeadKnockout MiceMalignant NeoplasmsTumor ProgressionPathway InteractionsCancer EtiologyGenerationsTransfectionYeast Two Hybrid System
Grant awards (56)
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression$320,588
R01 · FY2015 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$320,588
R01 · FY2015 · CA · contact PI
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression$310,970
R01 · FY2014 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$310,970
R01 · FY2014 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$301,353
R01 · FY2013 · CA · contact PI
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression$301,353
R01 · FY2013 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$320,588
R01 · FY2012 · CA · contact PI
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression$320,588
R01 · FY2012 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$309,964
R01 · FY2012 · CA · contact PI
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression$320,588
R01 · FY2011 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$319,810
R01 · FY2011 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$309,964
R01 · FY2011 · CA · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$283,822
R01 · FY2011 · CA · contact PI
Androgen Receptor Roles in Liver Cancer Incidence and Progression$283,822
R01 · FY2011 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2010 · CA · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2010 · CA · contact PI
Androgen Receptor Roles in Liver Cancer Incidence and Progression$292,600
R01 · FY2010 · CA · contact PI
Androgen Receptor in B Cell Development and Functions$291,351
R01 · FY2010 · DK · contact PI
Androgen Receptor in B Cell Development and Functions$39,270
R01 · FY2010 · DK · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2009 · CA · contact PI
Androgen Receptor in B Cell Development and Functions$294,294
R01 · FY2009 · DK · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2009 · CA · contact PI
Androgen Receptor Roles in Liver Cancer Incidence and Progression$292,600
R01 · FY2009 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2008 · CA · contact PI
Androgen Receptor in B Cell Development and Functions$294,294
R01 · FY2008 · DK · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2008 · CA · contact PI
Androgen Receptor Roles in Liver Cancer Incidence and Progression$292,600
R01 · FY2008 · CA · contact PI
Androgen Receptor in B Cell Development and Functions$300,300
R01 · FY2007 · DK · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2007 · CA · contact PI
Androgen Receptor Roles in Liver Cancer Incidence and Progression$292,600
R01 · FY2007 · CA · contact PI
Single and Double Knockout of TR2 and TR4 Receptors$361,428
R01 · FY2006 · DK · contact PI
Suppression of Androgen Receptor by PTEN$261,940
R01 · FY2006 · DK · contact PI
Single and Double Knockout of TR2 and TR4 Receptors$370,125
R01 · FY2005 · DK
Androgen Receptor in Prostate Cancer and Bone$277,200
R01 · FY2005 · DK
Suppression of Androgen Receptor by PTEN$268,243
R01 · FY2005 · DK
Single and Double Knockout of TR2 and TR4 Receptors$370,125
R01 · FY2004 · DK
TR4 ORPHAN RECEPTOR IN TESTIS$279,125
R01 · FY2004 · DK
Induction of AR Transactivation by DHT and E2$279,125
R01 · FY2004 · DK
Androgen Receptor in Prostate Cancer and Bone$277,200
R01 · FY2004 · DK
Suppression of Androgen Receptor by PTEN$268,243
R01 · FY2004 · DK
Single and Double Knockout of TR2 and TR4 Receptors$370,125
R01 · FY2003 · DK
TR4 ORPHAN RECEPTOR IN TESTIS$279,125
R01 · FY2003 · DK
Induction of AR Transactivation by DHT and E2$279,125
R01 · FY2003 · DK
Androgen Receptor in Prostate Cancer and Bone$277,200
R01 · FY2003 · DK
Suppression of Androgen Receptor by PTEN$268,243
R01 · FY2003 · DK
Suppression of Androgen Receptor by PTEN$305,156
R01 · FY2002 · DK
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER$288,159
R01 · FY2002 · DK
Induction of AR Transactivation by DHT and E2$279,125
R01 · FY2002 · DK
TR4 ORPHAN RECEPTOR IN TESTIS$279,125
R01 · FY2002 · DK
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER$281,242
R01 · FY2001 · DK
Induction of AR Transactivation by DHT and E2$279,125
R01 · FY2001 · DK
TR4 ORPHAN RECEPTOR IN TESTIS$279,125
R01 · FY2001 · DK
AR-ASSOCIATED PROTEINS IN PROSTATE CARCINOGENESIS$267,249
R01 · FY2001 · CA
T VS DHT SPECIFIC ANTIANDROGENS IN PROSTATE CANCER$334,543
R01 · FY2000 · CA
TR2 AND TR3 ORPHAN RECEPTORS IN PROSTATE CANCER$274,525
R01 · FY2000 · DK
AR-ASSOCIATED PROTEINS IN PROSTATE CARCINOGENESIS$260,404
R01 · FY2000 · CA